FDA advisory panel discussion underway for Pfizer booster shots
The FDA's independent advisory committee meeting is now underway to debate Pfizer's booster shots.
After a full day of presentations, Q&A and debate, the committee will vote at about 4:45 p.m. ET on whether a booster dose is safe enough for widespread use and whether it's necessary and effective at improving protection levels against COVID-19.
The vote will be non-binding. The FDA is not required to follow the advisory committee’s recommendations but generally does so. After that vote, the FDA will formally amend its current vaccine approval for Pfizer.
Next week, the matter heads to the CDC’s independent advisory panel whose members will weigh in on who should get a booster and when. The CDC Director will then formally sign off on what the panel recommends.
-ABC News' Sasha Pezenik